Another company involved in using AI to repurpose failed drugs ā€“ as well as drugs that have already been approved ā€“ is ...
Scientists have developed a coffee machine-sized 3D bioprinter that produces human-like tissue in a move they hope could ...
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Muskā€™s cost-cutting measures could slow drug ...
In regard to whatā€™s happening now with NIH, the main thing to do is diversify. You raise both non-dilutive funding through ...
BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.
While PD-1/PD-L1 blockade has demonstrated remarkable clinical successes, recent studies suggest that its novel target has a ...
Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers discovered a key process where malarial parasites take up a human blood cell ...
Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
Variations in regulatory requirements across regions often create inefficiencies in drug developmentā€”for example, differences in manufacturing standards and stability testing protocols can lead ...